Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

High-Risk Coronary Atherosclerotic Plaque Assessment by Coronary Computed Tomography Angiography—Should We Use It?

High-Risk Coronary Atherosclerotic Plaque Assessment by Coronary Computed Tomography... Risk Stratification of Patients With Chest Pain and High-Risk Plaque Original Investigation Research Invited Commentary High-Risk Coronary Atherosclerotic Plaque Assessment by Coronary Computed Tomography Angiography— Should We Use It? Raymond J. Gibbons, MD Coronary computed tomography angiography (CTA) has an tions and correctly includes stroke as an end point. The increasing role in the diagnostic and prognostic assessment of PROMISE trial included symptomatic patients with SIHD; patients with stable ischemic heart disease (SIHD). The stroke was not an end point. A more inclusive analysis would PROMISE trial has tested the have relied on historical variables of symptomatic patients, hypothesis that coronary CTA which would have included eliciting histories of peripheral vas- Related article page 144 anatomic assessment of pa- cular disease, cerebrovascular disease, and more details re- tients with SIHD would re- garding symptoms (eg, the presence of chest pain, dyspnea, duce cardiac events compared with conventional stress test- and typical angina, or not). These important variables are in- ing, but it has not found an advantage for a coronary CTA cluded in the Supplement of the study by Ferencik et al, but strategy. it is not clear whether they were ever considered in the analy- The PROMISE (Prospective http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Cardiology American Medical Association

High-Risk Coronary Atherosclerotic Plaque Assessment by Coronary Computed Tomography Angiography—Should We Use It?

JAMA Cardiology , Volume 3 (2) – Feb 10, 2018

Loading next page...
 
/lp/jama/high-risk-coronary-atherosclerotic-plaque-assessment-by-coronary-FhWeY5HyvI

References (9)

Publisher
American Medical Association
Copyright
Copyright 2018 American Medical Association. All Rights Reserved.
ISSN
2380-6583
eISSN
2380-6591
DOI
10.1001/jamacardio.2017.5016
Publisher site
See Article on Publisher Site

Abstract

Risk Stratification of Patients With Chest Pain and High-Risk Plaque Original Investigation Research Invited Commentary High-Risk Coronary Atherosclerotic Plaque Assessment by Coronary Computed Tomography Angiography— Should We Use It? Raymond J. Gibbons, MD Coronary computed tomography angiography (CTA) has an tions and correctly includes stroke as an end point. The increasing role in the diagnostic and prognostic assessment of PROMISE trial included symptomatic patients with SIHD; patients with stable ischemic heart disease (SIHD). The stroke was not an end point. A more inclusive analysis would PROMISE trial has tested the have relied on historical variables of symptomatic patients, hypothesis that coronary CTA which would have included eliciting histories of peripheral vas- Related article page 144 anatomic assessment of pa- cular disease, cerebrovascular disease, and more details re- tients with SIHD would re- garding symptoms (eg, the presence of chest pain, dyspnea, duce cardiac events compared with conventional stress test- and typical angina, or not). These important variables are in- ing, but it has not found an advantage for a coronary CTA cluded in the Supplement of the study by Ferencik et al, but strategy. it is not clear whether they were ever considered in the analy- The PROMISE (Prospective

Journal

JAMA CardiologyAmerican Medical Association

Published: Feb 10, 2018

There are no references for this article.